Navigation Links
Epigenetics studies take root in plants
Date:3/22/2013

WHAT: Biologist Mary Gehring, Ph.D. is The Pew Charitable Trusts' featured biomedical researcher of the month for her creative research on epigenetics in plants. Using the weed Arabidopsis as a model for human embryonic development, Gehring's lab at the Whitehead Institute for Biomedical Research aims to understand the environmental factors governing which genes are turned on and off in seeds. Her findings have the potential to shed light on diseases associated with chemical modifications to chromosomes, including cancer.

Gehring's story is part of a "Biomedical Researcher of the Month" series recently launched by Pew. Since 1985, Pew's biomedical programs have provided funding to more than 500 early-career scientists who show outstanding promise in science with the potential to advance human health. The scholars' exceptional research has earned them Nobel Prizes, Lasker Awards, MacArthur Genius Awards and other distinctionsincluding a 2013 Rosalind Franklin Young Investigator Award for Gehring.

WHO: Experts are available for interviews regarding Dr. Morris' research and the program:

  • Mary Gehring, Ph.D., assistant professor of biology, Massachusetts Institute of Technology Member, Whitehead Institute for Biomedical Research

  • Anita Pepper, Ph.D., director of the Pew Programs in the Biomedical Sciences

WHERE: Visit http://www.pewhealth.org/other-resource/Learning-How-Genetic-Seeds-Are-Sown-85899461360 to read the full profile story.


'/>"/>

Contact: Chelsea Toledo
ctoledo@pewtrusts.org
202-540-6846
Pew Health Group
Source:Eurekalert

Page: 1

Related biology news :

1. Epigenetics mechanism may help explain effects of moms nutrition on her childrens health
2. Life experiences put their stamp on the next generation: New insights from epigenetics
3. Epigenetics shapes fate of brain vs. brawn castes in carpenter ants
4. Study finds epigenetics, not genetics, underlies homosexuality
5. Sick from stress? Blame your mom… and epigenetics
6. Not by DNA alone: How the epigenetics revolution is fostering new medicines
7. Epigenetics and epidemiology -- hip, hype and science
8. Series of studies first to examine acupunctures mechanisms of action
9. Shiner Beers launches nationwide support of TGen diabetes studies
10. Analytical trick accelerates protein studies
11. Virginia Tech expands sports concussion-risk studies to include hockey and baseball
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2016)... 2016 Sensory Inc ., a ... for consumer electronics, and VeriTran , a ... industry, today announced a global partnership that will ... authenticate users of mobile banking and mobile payments ... software which requires no specialized biometric scanners, yet ...
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... DIEGO , Dec. 8, 2016  Renova™ ... for congestive heart failure and type 2 diabetes, ... for a novel adeno-associated virus (AAV) vector developed ... , M.D., Ph.D., at Stanford University. The company ... its paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... 8, 2016 Oxford Gene Technology ... SureSeq™ NGS panel range with the launch of the SureSeq ... study of variants in familial hypercholesterolemia (FH). The panel delivers ... on a single small panel and allows customisation by ,mix ... all exons for LDLR , P C ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... This CAST ... approvals for biotech crops. The authors focus on the economic effects in countries that ... approval of new biotech crops and the resultant risk of low level presence (LLP) ...
(Date:12/8/2016)... SEOUL, South Korea , Dec. 8, 2016 /PRNewswire/ ... completed a $21 billion KRW (US $18.9M) Series A ... Management, Kolon Investment, G.N. Tech Venture and SNU Bio ... by Eutilex to 30.5 billion KRW (US $27.7M) since ... will help Eutilex to bolster the development and commercialization ...
Breaking Biology Technology: